1.

Record Nr.

UNINA9910965700403321

Titolo

Borderline case : international tax policy, corporate research and development, and investment / / edited by James M. Poterba

Pubbl/distr/stampa

Washington, D.C., : National Academy Press, 1997

ISBN

9786612081439

9781282081437

1282081438

9780309518345

0309518342

9780585020945

0585020949

Edizione

[1st ed.]

Descrizione fisica

1 online resource (168 p.)

Collana

U.S. industry, restructuring and renewal

Altri autori (Persone)

PoterbaJames M

Disciplina

336.24/3/0973

Soggetti

International business enterprises - Taxation - United States

Research, Industrial - Taxation - United States

Research and development tax credit - United States

Capital investments - United States

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

"Board on Science, Technology, and Economic Policy, National Research Council."

Papers presented at a conference held at the National Academy of Sciences in Washington, D.C., on February 14, 1997.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

section 1. International tax policy and technology investments -- section 2. Industry perspectives on the impact of international tax rules -- section 3. Tax reform : prescriptions and prospects.

Sommario/riassunto

The growing integration of world markets for capital and goods, coupled with the rise of instantaneous worldwide communication, has made identification of corporations as "American," "Dutch," or "Japanese" extremely difficult. Yet tax treatment does depend of where a firm is chartered. And, as Borderline Case documents, there is little doubt that tax rules for firms doing business in several nations--firms that account for more than three-quarters of corporate R&D spending in the United States--have substantial effects on corporate



decisionmaking and, ultimately, U.S. competitiveness. This book explores the impact of the U.S. tax code and its incentives on the international activities of U.S.- and foreign-based firms: basic research outlays, expenditures on product and process development, and plant and equipment investment. The authors include industry experts from large multinational firms in technology and pharmaceuticals, academic researchers who have explored the quantitative impact of tax provisions on R&D, and tax policy analysts who have examined international tax rules in the broader context of tax reform. These experts look at how corporate investment and R&D are shaped by specific tax provisions, such as the definition of taxable income, relative tax burdens on domestic and foreign business, taxation of earnings repatriated to the United States, deductibility of expenses of worldwide operations, and U.S. corporate taxes relative to other countries. The volume explores prescriptions and prospects for tax reform and reviews major reform proposals and their implications for the behavior of multinational business.